Abstract: Compounds useful for biotin-free proximity labeling are provided. Also provided are methods for biotin-free labeling of biomolecules in proximity to a target in a cell, which involve attaching an engineered labeling enzyme to the target; and contacting the cell to a compound as disclosed, which is a substrate of the engineered labeling enzyme and which includes a label moiety, wherein the biomolecules in proximity to the target are labeled.

Abstract: The present invention provides a compound having the structure: wherein R1 is H or a protecting group; R2 and R3 are each independently H, halo, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 alkyl-C(O)NHR6, C1-C6 alkyl-C(O)OR6, wherein R6 is H, C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl, or R2 and R3 combine to form a 3-7 membered cycloalkyl, heterocycloalkyl, aryl or heteroaryl ring; and R4 and R5 are each independently halo.

Abstract: The application discloses a compound having a moiety that is either an affinity tag-containing moiety or a protein-manipulation moiety, a self-labeling protein (SLP) ligand, and a rhodamine dye linking the affinity tag-containing moiety or a protein-manipulation moiety to the SLP ligand. Also disclosed is a complex, which includes the compound and a SLP. Also disclosed is a method that involves contacting the compound and a SLP with a cell, and visualizing fluorescence in the cell or purifying the SLP and associated biological components from the cell.

Abstract: This invention describes software which allows a single content receiver to receive minoring streams from multiple heterogeneous platforms

Abstract: A screen mirroring receiving device capable of receiving mirroring streams comprising audio-visual data, the mirroring streams conforming to different vendor-provided screen-mirroring protocols, and capable of processing the mirroring streams for audio-visual rendering.

Abstract: The present invention provides a compound having the structure: wherein R1 is H or a protecting group; R2 and R3 are each independently H, halo, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 alkyl-C(O)NHR6, C1-C6 alkyl-C(O)OR6, wherein R6 is H, C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl, or R2 and R3 combine to form a 3-7 membered cycloalkyl, heterocycloalkyl, aryl or heteroaryl ring; and R4 and R5 are each independently halo.

Abstract: A screen mirroring receiving device capable of receiving mirroring streams comprising audio-visual data, the mirroring streams conforming to different vendor-provided screen-mirroring protocols, and capable of processing the mirroring streams for audio-visual rendering.

Abstract: A screen mirroring receiving device capable of receiving mirroring streams comprising audio-visual data, the mirroring streams conforming to different vendor-provided screen-mirroring protocols, and capable of processing the mirroring streams for audio-visual rendering.

Abstract: This invention describes software which allows a single content receiver to receive mirroring streams from multiple heterogeneous platforms

Abstract: This invention is directed to a receiver device to simultaneous display mirroring streams conforming to at least two different screen mirroring protocols, the different screen mirroring protocols being provided by different device vendors.

Abstract: This invention relates to a thermoluminescent phosphor for the measurement of low radiation doses, including calcium sulphate (CaSO4), Dysprosium (Dy) and manganese (Mn), wherein Dy and Mn are present as dopants. A process for the preparation of a thermoluminescent phosphor is also provided. The process includes the steps of: separately dissolving calcium sulphate (CaSO4), Dysprosium chloride (DyCh) and Manganese chloride (MnC) in hot concentrated sulphuric acid, to obtain sulphuric acid solutions of CaSO4, DyCb and MnCb; mixing the solutions; and followed by slow evaporation of the solvent to obtain a powder of microcrystalline phosphor of CaSO4:Dy, Mn.

Abstract: This invention describes software which allows a single content receiver to receive mirroring streams from multiple heterogeneous platforms.

Abstract: This invention relates to a thermoluminescent phosphor for the measurement of low radiation doses, including calcium sulphate (CaSO4), Dysprosium (Dy) and manganese (Mn), wherein Dy and Mn are present as dopants. A process for the preparation of a thermoluminescent phosphor is also provided. The process includes the steps of: separately dissolving calcium sulphate (CaSO4), Dysprosium chloride (DyCh) and Manganese chloride (MnC) in hot concentrated sulphuric acid, to obtain sulphuric acid solutions of CaSO4, DyCb and MnCb; mixing the solutions; and followed by slow evaporation of the solvent to obtain a powder of microcrystalline phosphor of CaSO4:Dy, Mn.

Abstract: Performance tracking of computing systems can be provided by monitoring, determining performance states, and displaying health information. Capacity planning recommendations can be provided by monitoring performance of a software application, determining a plurality of performance state transitions of the software application, and, based on the transitions, making capacity planning recommendations. Performance state transitions can be selected from a set of transitions between four possible quadrant states. Performance of a software application can be categorized into one of the four possible quadrant states from. Capacity planning recommendations can be provided by a capacity planning framework. The framework can comprise a performance monitoring module for monitoring performance of software applications, a quadrant tracking module for determining performance state transitions, and a capacity planning module for making capacity planning recommendations based on the transitions.

Abstract: A stabilized pharmaceutical composition of benzimidazole compounds preferably amorphous form of esomeprazole and a process for preparing the same. The pharmaceutical compositions formulated into solid dosage forms preferably multiple unit tablet dosage forms and capsules and a method for preparing the same.

Abstract: The present invention discloses modified-release oral dosage forms of an azabicyclo derivative or its pharmaceutically acceptable salts, solvates, esters, enantiomers, diastereomers, N-oxides and polymorphs; and processes for the preparation thereof. The modified release formulation comprises an azabicyclo derivative, at least one rate-controlling polymer and at least one pharmaceutically acceptable excipient which provides therapeutically effective plasma levels of the active ingredient for a period of up to 24 hours.

Abstract: The present invention provides extended-release matrix formulations comprising a therapeutically effective amount of morphine or salt thereof, one or more hydrophilic controlled release polymers and one or more pharmaceutically acceptable excipients. The formulations provide extended release of morphine or salt thereof over a specified period of time after oral administration in humans or animals.

Abstract: Performance tracking of computing systems can be provided by monitoring, determining performance states, and displaying health information. Capacity planning recommendations can be provided by monitoring performance of a software application, determining a plurality of performance state transitions of the software application, and, based on the transitions, making capacity planning recommendations. Performance state transitions can be selected from a set of transitions between four possible quadrant states. Performance of a software application can be categorized into one of the four possible quadrant states from. Capacity planning recommendations can be provided by a capacity planning framework. The framework can comprise a performance monitoring module for monitoring performance of software applications, a quadrant tracking module for determining performance state transitions, and a capacity planning module for making capacity planning recommendations based on the transitions.